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Myelination of axon tracts in the vertebrate central
nervous system (CNS) is essential for rapid impulse
conduction. The timing of myelination differs between
different tracts in a pattern that is consistent within a
single species. The molecular mechanisms underlying this
striking feature of neural development remain unknown.
Myelin is formed by oligodendrocytes within the CNS.
Oligodendrocyte progenitor cells (OPCs) arise in the sub-
ventricular zone (SVZ) of the developing brain and
migrate from this region to populate white matter areas of
the brain. Following arrival in the region of axon targets,
OPCs withdraw from the cell cycle and differentiate into
non-migratory, multi-branched oligodendrocytes, which
mature further to ensheathe and myelinate the axons. The
bulk of this migration, differentiation and myelination
occurs when neuronal pathways are already well estab-
lished. Consequently, migrating OPCs must navigate —
sometimes for considerable distances — around, over and
often along the axons they will ultimately myelinate
before differentiating at the appropriate time [1]. 
What controls the timing of OPC differentiation and
myelination? Cell culture studies show that OPC differen-
tiation is a default pathway which can occur in the absence
of any extrinsic signals. Further, there appears to be an
internal timing mechanism in the OPCs, such that the
daughters of a single OPC grown in vitro in the absence of
neurons become unresponsive to mitogenic growth
factors, withdraw from the cell cycle, and then differenti-
ate more or less synchronously [2]. But if this were the
sole mechanism regulating OPC differentiation in vivo,
myelination of the different regions of the CNS would
also occur synchronously, unless OPCs destined for differ-
ent tracts were born at different times in the SVZ and
then followed distinct pathways from this site of common
origin. Currently, there is no direct evidence to support
this model. An alternative would be that loss of growth
factor responsiveness permits differentiation, but that
other, local cues instruct the timing in the different tracts.
Such a model makes two predictions: first, that local cues
should be identifiable; and second, that the cessation of
proliferation associated with loss of growth factor respon-
siveness will not inevitably lead to differentiation, as sug-
gested by the in vitro data. Recent evidence suggests that
Notch signalling may regulate OPC differentiation in
exactly this way [3]. 
The Notch receptor is a large transmembrane protein
which interacts with membrane-bound ligands — Delta or
Serrate/Jagged — present on the surfaces of adjacent cells.
Ligand binding to Notch activates specific intracellular
signalling pathways, which transduce inhibitory signals
from the cytoplasm to the nucleus and, as a consequence,
repress cellular differentiation (Figure 1) [4–7]. The Notch
signalling pathway appears to be well conserved, both
structurally and functionally, across species. Signalling
through activated Notch is known both to control multiple
cell fate determinations (in both invertebrates and verte-
brates) and to inhibit developmental processes, such as
neurogenesis [8–11] and myogenesis [12–14].
That Notch–ligand interactions can inhibit terminal
differentiation is indicated by studies of muscle cell differ-
entiation in vitro. For example, Lindsell et al. [12] have
recently shown that Notch-1-expressing myoblasts fail to
differentiate when co-cultured with L cells expressing the
Notch ligand Jagged. Activation of Notch by Jagged was
found to inhibit the expression of the muscle regulatory
gene myogenin. Taking a similar approach, Wang et al. [3]
found that oligodendrocyte differentiation could also be
inhibited by Notch–Jagged interactions. OPCs isolated
from the rat optic nerve were grown in differentiating
medium on a monolayer of Jagged-1-expressing L cells.
After three days in culture, a considerable proportion of
these cells had failed to differentiate into oligodendro-
cytes. In contrast, control cultures grown on wild type L
cells had nearly all differentiated. Similar effects on differ-
entiation were observed when OPCs were grown in condi-
tioned medium from a cell line engineered to secrete a
soluble form of Delta. The Notch pathway could therefore
provide the mechanism underlying control of OPC differ-
entiation, with signalling through activated Notch main-
taining cells in an undifferentiated state. 
Wang et al. [3] have also demonstrated that Notch 1 and
one of its ligands, Jagged 1, are co-expressed in develop-
ing rat optic nerve in vivo. Notch 1 is expressed in oligo-
dendroglial cells within the nerve, while Jagged 1 is
expressed in retinal ganglion cells and along their axons
which project in the optic nerve. Levels of expression of
Notch 1 and Jagged 1 in these different cell types appear
to be coordinately and developmentally down-regulated
with a time course that parallels myelination. Conse-
quently, as more and more of the optic nerve becomes
myelinated, levels of both Notch 1 and Jagged 1 corre-
spondingly decline. As OPCs are known to migrate along
unmyelinated axons in the developing rat optic nerve [1],
Notch–Jagged interactions may occur and play a role in
preventing premature OPC differentiation. The cell-type-
specific distribution of Notch 1 and Jagged 1 is consistent
with this hypothesis; OPCs should express Notch 1 on
their surfaces if Notch signalling does indeed control OPC
differentiation, while Jagged 1 should be expressed by any
cells that may potentially interact with OPCs to inhibit
their differentiation. Taken together with the in vitro data,
these observations support a role for Notch signalling in
control of the timing of OPC differentiation (Figure 2).
Newly-formed oligodendrocytes isolated from developing
rat optic nerve were also found to express Jagged 1 in addi-
tion to Notch 1 [3]. This suggests that Jagged 1 expression
may be up-regulated as a consequence of OPC differentia-
tion. It is tempting to speculate that a basic-
helix–loop–helix protein may regulate expression of Jagged
1 in a similar manner to the regulation of Delta expression
by Mash 1/NeuroD during mouse neurogenesis (Figure 1).
Regardless of the detailed mechanism, in regions where
sufficient oligodendrocytes have been generated, newly-
formed oligodendrocytes that express Jagged 1 could signal
to neighbouring cells to inhibit further OPC differentia-
tion. A consequence of this inhibition would be to maintain
a population of undifferentiated OPCs in the adult 
CNS after myelination had been completed, just as
Notch–ligand interactions are thought to maintain a stem
cell population in early neurogenesis [8–11].
Consistent with the hypothesis that a loss of sensitivity to
mitogenic factors is permissive for differentiation, rather
than instructive, activated Notch appears to inhibit OPC
differentiation without stimulating proliferation [3].
Oligodendrocyte progenitor cells grown in the presence of
Jagged 1, which inhibits their differentiation, did not
incorporate the thymidine analogue BrdU into their
nuclei. BrdU uptake could, however, be stimulated in the
presence of the mitogen platelet-derived growth factor
(PDGF). This is an important observation, as it shows that
Notch activation can uncouple proliferation from differen-
tiation and, as a consequence, serve to maintain cells in a
state of quiescence (extended G0 phase?) long after the
completion of development. 
Such quiescent OPCs — as perhaps typified by the
observed OPCs present in adult CNS — could be
recruited following injury to participate in remyelination.
The signals which activate repair might thus concomi-
tantly inactivate the Notch pathway. If so, the efficiency
and effectiveness of repair might be dependent on inacti-
vation of the Notch pathway. The demonstration of non-
dividing OPCs in human multiple sclerosis lesions [15], in
which chronic demyelination is present, suggests that
inhibitory signals are present in such lesions which may
prevent OPC differentiation into new myelin-forming
oligodendrocytes. An attractive hypothesis would be that
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Figure 1
The Notch signalling pathways in Drosophila
and mouse. (a) Inhibition of Drosophila
neurogenesis through the Notch pathway. A
newly-committed neuroblast expresses the
Notch ligand Delta (Dl), which signals to an
uncommitted neighbouring cell. Notch
activation signals via ‘Suppressor of Hairless’
(Su(H)) to the nucleus, activating Enhancer of
split (E(Spl)) complex genes. E(Spl) genes
encode repressors of the achaete-scute (ac-
sc) complex, which in turn encode
transcription factors required for Dl expression
and neurogenesis. The receiving cell thus
becomes an epidermoblast rather than a
neuroblast. (b) Inhibition of mouse
neurogenesis through the Notch pathway. The
prospective neuron expresses Delta-like 1
(Dll 1), through which it signals to an adjacent
uncommitted neuroepithelial cell. Activated
Notch signals via the Su(H) homologue
‘Recombination signal sequence Binding
Protein for Jκ genes’ (RBP-Jκ) to the nucleus,
activating Hes 5, the vertebrate E(Spl)
homologue. Hes 5 represses Mash 1 and
‘gene X’ (possibly neurogenin), thereby
inhibiting expression of both Dll 1 and
NeuroD. Mash 1 and NeuroD are transcription
factors required for vertebrate neurogenesis,
so Notch signalling in the mouse serves both
to maintain a population of neuroepithelial
cells in a pluripotent state, ready for
recruitment as required, and to inhibit
neurogenesis. (Adapted from [4].)
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expression of Notch ligands by reactive astrocytes and
other cells within the lesions could inhibit OPC differenti-
ation. Inhibitors of Notch activation may therefore, offer
novel therapies for demyelinating disease.
Clearly, signalling through activated Notch could be an
important regulator of OPC differentiation in the develop-
ing rat optic nerve. Further studies in which Notch activa-
tion is manipulated in vivo are required to test this
hypothesis. It also remains to be established whether the
Notch pathway operates ubiquitously within the develop-
ing CNS to regulate the timing of OPC differentiation.
Certainly, an examination of late myelinating tracts, par-
ticularly with respect to the expression of Jagged (and
other Notch ligands) and the timing of myelination would
be interesting. It might also prove informative to look at
myelination in children with Alagille syndrome, where
mutations in Notch 1 lead to multiple developmental
abnormalities in liver, heart, eye and lung [16,17]. 
Equally as interesting would be a study of non-myelinated
axons, such as those of rat cerebellar granule neurons.
Wang et al. [3] have predicted that Jagged or other Notch
ligands may persist on these axons and continue to inhibit
the generation of myelin-forming oligodendrocytes. This
would maintain these axons in an unmyelinated state and
provide a wider role for Notch–ligand signalling in myeli-
nation, determining the timing of myelination and also
maintaining myelin patterns in the fully developed CNS.
This is just speculation at the moment, but the demonstra-
tion that mutations in another Notch, Notch 3, cause the
human CNS disease known as ‘cerebral autosomal domi-
nant arteriopathy with subcortical infarcts and leukoen-
cephalopathy’ (CADASIL) in adults [18] emphasises that
Notch signalling is a regulator of cell behaviour throughout
life. The role of the Notch pathway in the etiology of dis-
eases of both development and adult life will thus be of
interest to clinical and non-clinical neuroscientists alike.
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The proposed role of the Notch pathway in regulating
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maturation remains to be determined. However, Jagged expression by
axons, newly-formed oligodendrocytes and possibly other cells within
the optic nerve may not only be important in the timing of
oligodendrocyte differentiation and maturation but may play a role in
maintaining a pool of OPCs, which could be drawn from as needed
during both development and repair.
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